Sodium Chloride NDC 0641-6144

NDC codes

FDA NDC Directory

Product NDC (as listed)0641-6144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00641-6144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0641-6144-25	00641614425	25 VIAL in 1 CARTON (0641-6144-25) / 10 mL in 1 VIAL (0641-6144-01)Marketed from Sep 24, 2013

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Chloride
Generic name (nonproprietary): sodium chloride
Active ingredients: Sodium chloride — 9 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201833
Marketing start: Sep 24, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 0641-6144_0950e98d-bfec-40e8-9f56-ba90e0d6e8c8SPL ID 0950e98d-bfec-40e8-9f56-ba90e0d6e8c8SPL set ID e5ee8caa-b6ca-45ba-98fb-8305e6282141RxCUI 1807636, 1807637UNII 451W47IQ8X
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400641614425 followed by a unit qualifier and the quantity

Package 00641-6144-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 10, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE This parenteral preparation indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201833

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201833
Product	Strength	Form · route	Labeler	Product NDC
Sodium Chloride	Sodium chloride 9 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0641-0497